Hipólito, A.; Mendes, C.; Martins, F.; Lemos, I.; Francisco, I.; Cunha, F.; Almodôvar, T.; Albuquerque, C.; Gonçalves, L.G.; Bonifácio, V.D.B.;
et al. H2S-Synthesizing Enzymes Are Putative Determinants in Lung Cancer Management toward Personalized Medicine. Antioxidants 2024, 13, 51.
https://doi.org/10.3390/antiox13010051
AMA Style
Hipólito A, Mendes C, Martins F, Lemos I, Francisco I, Cunha F, Almodôvar T, Albuquerque C, Gonçalves LG, Bonifácio VDB,
et al. H2S-Synthesizing Enzymes Are Putative Determinants in Lung Cancer Management toward Personalized Medicine. Antioxidants. 2024; 13(1):51.
https://doi.org/10.3390/antiox13010051
Chicago/Turabian Style
Hipólito, Ana, Cindy Mendes, Filipa Martins, Isabel Lemos, Inês Francisco, Fernando Cunha, Teresa Almodôvar, Cristina Albuquerque, LuÃs G. Gonçalves, Vasco D. B. Bonifácio,
and et al. 2024. "H2S-Synthesizing Enzymes Are Putative Determinants in Lung Cancer Management toward Personalized Medicine" Antioxidants 13, no. 1: 51.
https://doi.org/10.3390/antiox13010051
APA Style
Hipólito, A., Mendes, C., Martins, F., Lemos, I., Francisco, I., Cunha, F., Almodôvar, T., Albuquerque, C., Gonçalves, L. G., Bonifácio, V. D. B., Vicente, J. B., & Serpa, J.
(2024). H2S-Synthesizing Enzymes Are Putative Determinants in Lung Cancer Management toward Personalized Medicine. Antioxidants, 13(1), 51.
https://doi.org/10.3390/antiox13010051
